Alexia Blake, Head of Research & Product Development, Cellular Goods (CBX.L) Interview
A cannabinoids company backed by David Beckham become the first company of its kind to formally unveil plans for a main London stock market debut.
\n
\n\n\nCellular Goods, a UK-based provider of premium consumer products based on biosynthetic cannabinoids.
\n
\nWith the legal cannabis industry set to be the next true growth market, and estimated to be worth \xa32.31 billion by 2024, businesses and investors are in a prime position to capitalise on this first-mover advantage.
\n
\n\n\nCellular Goods is the first provider of premium consumer products based on biosynthetic cannabinoids to join the London stock market.
\n
\n\n\nThe company, which is run by Alexis Abraham, has sold a minority stake to DB Ventures, the former Manchester United and England midfielder\u2019s global brand management and commercial ventures arm, according to people close to the situation.
\n
\nhttps://www.share-talk.com/alexia-blake-head-of-research-product-development-cellular-goods-cbx-l-interview/\n\n\n
\n
\n\n